SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

White Matthew J

(Last)

(First)

(Middle)

C/O LINDE PLC

THE PRIESTLEY CENTRE, 10 PRIESTLEY ROAD

(Street)

GUILDFORD, SURREY

GU2 7XY

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
LINDE PLC [ LIN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/21/2022

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Ordinary Shares	03/21/2022		M		12,510⁽¹⁾	A	$0	47,052	D
Ordinary Shares	03/21/2022		F		5,798⁽²⁾	D	$311.66	41,254	D
Ordinary Shares	03/21/2022		M		6,170⁽¹⁾	A	$0	47,424	D
Ordinary Shares	03/21/2022		F		2,860⁽²⁾	D	$311.66	44,564	D
Ordinary Shares	03/21/2022		M		4,170⁽³⁾	A	$0	48,734	D
Ordinary Shares	03/21/2022		F		1,933⁽²⁾	D	$311.66	46,801	D
Ordinary Shares								2,913.328	I	401(k)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units	⁽³⁾	03/21/2022		M			4,170	⁽³⁾	⁽³⁾	Ordinary Shares	4,170	$0	0	D
Performance Share Units	⁽⁴⁾	03/21/2022		A		12,510		⁽⁴⁾	⁽⁴⁾	Ordinary Shares	12,510	$0	12,510	D
Performance Share Units	⁽⁴⁾	03/21/2022		M			12,510	⁽⁴⁾	⁽⁴⁾	Ordinary Shares	12,510	$0	0	D
Performance Share Units	⁽⁵⁾	03/21/2022		A		6,170		⁽⁵⁾	⁽⁵⁾	Ordinary Shares5	6,170	$0	6,170	D
Performance Share Units	⁽⁵⁾	03/21/2022		M			6,170	⁽⁵⁾	⁽⁵⁾	Ordinary Shares	6,170	$0	0	D
Restricted Stock Units	$0⁽⁶⁾							⁽⁶⁾	⁽⁶⁾	Ordinary Shares	2,600		2,600	D
Restricted Stock Units	$0⁽⁷⁾							⁽⁷⁾	⁽⁷⁾	Ordinary Shares	3,260		3,260	D
Restricted Stock Units	$0⁽⁸⁾							⁽⁸⁾	⁽⁸⁾	Ordinary Shares	3,590		3,590	D
Stock Options (right to buy)	$270.99							03/07/2023⁽⁹⁾	03/07/2032	Ordinary Shares	22,535		22,535	D
Stock Option (right to buy)	$253.68							03/08/2022⁽¹⁰⁾	03/08/2031	Ordinary Shares	34,320		34,320	D
Stock Option (right to buy)	$173.13							03/09/2021⁽¹¹⁾	03/09/2030	Ordinary Shares	43,695		43,695	D
Stock Option (right to buy)	$176.63							03/20/2020⁽¹²⁾	03/20/2029	Ordinary Shares	47,020		47,020	D
Stock Option (right to buy)	$128.38							02/24/2016⁽¹³⁾	02/24/2025	Ordinary Shares	40,865		40,865	D
Stock Option (right to buy)	$102.22							02/23/2017⁽¹³⁾	02/23/2026	Ordinary Shares	85,205		85,205	D
Stock Option (right to buy)	$118.71							02/28/2018⁽¹³⁾	02/28/2027	Ordinary Shares	72,795		72,795	D
Stock Option (right to buy)	$154							02/27/2019⁽¹³⁾	02/27/2028	Ordinary Shares	64,665		64,665	D
Deferred Stock Units	⁽¹⁴⁾							⁽¹⁵⁾	⁽¹¹⁾	Ordinary Shares	1,192.919		1,192.919	D

Explanation of Responses:

1. Shares of common stock acquired pursuant to the payout of a performance share unit grant made on March 20, 2019 (the "PSU").

2. Shares of common stock withheld from the payout to cover tax withholdings.

3. Shares of common stock acquired pursuant to the payout of a restricted stock unit grant made on March 20, 2019

4. The PSU paid out on March 21, 2022 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2019-2021 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2019.

5. The PSU paid out on March 21, 2022 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2019-2021 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2019.

6. Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis.

7. Restricted Stock Units that will vest in full and payout on or about March 8, 2024 in Linde plc Ordinary Shares on a one-for-one basis.

8. Restricted Stock Units that will vest in full and payout on or about March 9, 2023 in Linde plc Ordinary Shares on a one-for-one basis.

9. Restricted Stock Units that will vest in full and payout on or about March 20, 2022 in Linde plc Ordinary Shares on a one-for-one basis.

10. This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.

11. This option vests over three years in three consecutive equal annual installments beginning on March 8, 2022.

12. This option vests over three years in three consecutive equal annual installments beginning on March 9, 2021.

13. This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant.

14. Conversion to Linde plc Ordinary Shares is on a 1-for-1 basis.

15. Deferred stock units acquired under the Linde Compensation Deferral Plan ("Plan"). The deferred stock units will payout in Linde plc Ordinary Share on a one-for-one basis in accordance with the Plan.

	Anthony M. Pepper, Attorney-in-Fact	03/23/2022
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.